Drug Enforcement Administration guidance allowing for more flexibility for practitioners to prescribe buprenorphine to new and existing patients with OUD via telephone during the nationwide public health emergency...

NYS Department of Health: protocols for essential personnel to return to work following COVID-19 exposure or infection. Updated 03/28/20.

OASAS guidance on the Drug Enforcement Administration's recent action of approving buprenorphine induction via telephone amid the COVID-19 pandemic.

COVID-19 guidance for Impaired Driver Screening and Assessment service providers.

NYS DOH Health Advisory to behavioral health providers regarding release from home isolation amid the COVID-19 pandemic.

Updated policies on reporting for court, probation and/or parole appearances amid the COVID-19 pandemic in New York State. Issued 03/26/20.

Resources for prevention providers and coalitions for providing prevention services amid the ongoing COVID-19 pandemic.

A NYS DOH update on specimen collection and handling to include nasal swab and oropharyngeal swab specimen alternative amid ongoing COVID-19 pandemic.

COVID-19 public health emergency response and 42 CFR Part 2 guidance amidst COVID-19 pandemic.

Guidance for providers on delivering telepractice services while maintaining patient confidentiality amid the COVID-19 pandemic. Issued 03/23/20.